Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements

v3.5.0.2
Fair Value Measurements
9 Months Ended
Oct. 01, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.  There is a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable.
 
Level 1 - Quoted prices in active markets for identical assets or liabilities.  These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets or liabilities.

Level 2 - Inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly.  These are typically obtained from readily available pricing sources for comparable instruments.

Level 3 - Unobservable inputs, where there is little or no market activity for the asset or liability.  These inputs reflect the reporting entity’s own assumptions of the data that market participants would use in pricing the asset or liability, based on the best information available in the circumstances.

The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of October 1, 2016:
(in millions)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
0.6

 
$

 
$

 
$
0.6

Short-term investments in marketable securities
0.8

 

 

 
0.8

Restricted cash
12.7

 

 

 
12.7

Derivatives

 
13.2

 

 
13.2

Total assets
$
14.1

 
$
13.2

 
$

 
$
27.3

 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

Derivatives
$

 
$
6.1

 
$

 
$
6.1

Other
3.9

 
27.6

 

 
31.5

Total liabilities at fair value
$
3.9

 
$
33.7

 
$

 
$
37.6

Liabilities measured at net asset value
 
 
 
 
 
 
15.0

Total liabilities
 
 
 
 
 
 
$
52.6


The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015:
(in millions)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
131.3

 
$
138.9

 
$

 
$
270.2

Short-term investments in marketable securities
0.8

 
10.7

 

 
11.5

Restricted cash
12.7

 

 

 
12.7

Derivatives

 
13.5

 

 
13.5

Total assets
$
144.8

 
$
163.1

 
$

 
$
307.9

 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

Derivatives
$

 
$
5.6

 
$

 
$
5.6

Other
3.8

 
34.6

 

 
38.4

Total liabilities at fair value
$
3.8

 
$
40.2

 
$

 
$
44.0

Liabilities measured at net asset value
 
 
 
 
 
 
11.3

Total liabilities
 
 
 
 
 
 
$
55.3



The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of October 3, 2015:
(in millions)
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
141.1

 
$
118.4

 
$

 
$
259.5

Short-term investments in marketable securities
0.8

 
31.7

 

 
32.5

Restricted cash
15.6

 

 

 
15.6

Derivatives

 
15.2

 

 
15.2

Total assets
$
157.5

 
$
165.3

 
$

 
$
322.8

 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

Derivatives
$

 
$
6.3

 
$

 
$
6.3

Other
6.5

 
33.6

 

 
40.1

Total liabilities at fair value
$
6.5

 
$
39.9

 
$

 
$
46.4

Liabilities measured at net asset value
 
 
 
 
 
 
11.1

Total liabilities
 
 
 
 
 
 
$
57.5



Refer to Note 5 – Financial Instruments for additional information related to the fair value of derivative assets and liabilities by class. Other liabilities shown in the tables above include certain deferred compensation plans of the Company. In addition to the items shown in the tables above, refer to Note 17 in the Notes to Consolidated Financial Statements in the 2015 Form 10-K for further discussion regarding the fair value measurements associated with the Company’s postretirement benefit plans.